Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
Article in Cochrane Database of Systematic Reviews (May 2020)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Roflumilast does not decrease COPD exacerbations in adequately treated patients, but subgroup analysis allows for shared decision making
Article in Clinical Research in Practice The Journal of Team Hippocrates (February 2019)
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials
Article in American Journal of Respiratory and Critical Care Medicine (May 2018)